NASDAQ : SGRY
Surgery Partners, Inc. — Key statistics
Healthcare · Medical Care Facilities · United States
Last price 23.21 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 3.01B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 3.01B |
| Enterprise Value | 6.86B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 129.71M |
| Shares Outstanding | 129.71M |
| Shares Change (YoY) | +1.28% |
| Shares Change (QoQ) | +0.36% |
| Owned by Insiders (%) | 1.82% |
| Owned by Institutions (%) | 74.57% |
| Float | 58.75M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | 96.91 |
| PS Ratio | 0.89 |
| Forward PS | 1.04 |
| PB Ratio | 1.80 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 16.05 |
| P/OCF Ratio | 11.67 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 2.04 |
| EV / EBITDA | 10.61 |
| EV / EBIT | 14.62 |
| EV / FCF | 36.57 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.95 |
| Quick Ratio | 1.44 |
| Debt / Equity | 1.17 |
| Debt / EBITDA | 5.51 |
| Debt / FCF | 21.68 |
| Interest Coverage | 1.60 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 2.32% |
| Return on Assets (ROA) | 3.66% |
| Return on Invested Capital (ROIC) | 5.12% |
| Return on Capital Employed (ROCE) | 6.28% |
| Weighted Average Cost of Capital (WACC) | 9.59% |
| Revenue Per Employee | $210,394 |
| Profits Per Employee | -$5,538 |
| Employee Count | 16,000 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 28.03 |
Taxes
| Measure | Value |
|---|
| Income Tax | 20.50M |
| Effective Tax Rate | 20.02% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.91 |
| 52-Week Price Change | +1.98% |
| 50-Day Moving Average | 15.13 |
| 200-Day Moving Average | 14.63 |
| Relative Strength Index (RSI) | 86.16 |
| Average Volume (20 Days) | 5,395,767 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 14.33M |
| Short Previous Month | 14.35M |
| Short % of Shares Out | 11.05% |
| Short % of Float | 24.39% |
| Short Ratio (days to cover) | 6.88 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 3.37B |
| Gross Profit | 757.90M |
| Operating Income | 469.20M |
| Pretax Income | 102.40M |
| Net Income | -88.60M |
| EBITDA | 646.40M |
| EBIT | 469.20M |
| Loss Per Share | -$0.69 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 216.70M |
| Total Debt | 4.07B |
| Net Cash | -3.85B |
| Net Cash Per Share | -$29.68 |
| Equity (Book Value) | 3.47B |
| Book Value Per Share | 12.88 |
| Working Capital | 547.50M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 258.00M |
| Capital Expenditures | -70.40M |
| Depreciation & Amortization | 177.20M |
| Net Borrowing | 119.80M |
| Free Cash Flow | 187.60M |
| FCF Per Share | $1.45 |
Margins
| Measure | Value |
|---|
| Gross Margin | 22.51% |
| Operating Margin | 13.94% |
| Pretax Margin | 3.04% |
| Profit Margin | -2.63% |
| EBITDA Margin | 19.20% |
| EBIT Margin | 13.94% |
| FCF Margin | 5.57% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -1.28% |
| Shareholder Yield | -1.28% |
| Earnings Yield | -2.98% |
| FCF Yield | 6.23% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $21.70 |
| Price Target Difference | -6.51% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | -2.85% |
| EPS Growth Forecast (3Y) | 1.22% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 0.83 |
| Piotroski F-Score | 5 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |